Page last updated: 2024-09-02

ecteinascidin 743 and Carcinoma, Hepatocellular

ecteinascidin 743 has been researched along with Carcinoma, Hepatocellular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beijnen, JH; Brandon, EF; den Arend, D; Klijn, JS; Lázaro, LL; Meijerman, I; Schellens, JH; Sparidans, RW	1

Other Studies

1 other study(ies) available for ecteinascidin 743 and Carcinoma, Hepatocellular

Article	Year
In-vitro cytotoxicity of ET-743 (Trabectedin, Yondelis), a marine anti-cancer drug, in the Hep G2 cell line: influence of cytochrome P450 and phase II inhibition, and cytochrome P450 induction. Anti-cancer drugs, 2005, Volume: 16, Issue:9 Topics: Antineoplastic Agents, Alkylating; Biotransformation; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dioxoles; Enzyme Induction; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Isoquinolines; Metabolic Detoxication, Phase II; Microsomes, Liver; Tetrahydroisoquinolines; Trabectedin	2005

Article

Year

In-vitro cytotoxicity of ET-743 (Trabectedin, Yondelis), a marine anti-cancer drug, in the Hep G2 cell line: influence of cytochrome P450 and phase II inhibition, and cytochrome P450 induction.

Anti-cancer drugs, 2005, Volume: 16, Issue:9

Topics: Antineoplastic Agents, Alkylating; Biotransformation; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dioxoles; Enzyme Induction; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Isoquinolines; Metabolic Detoxication, Phase II; Microsomes, Liver; Tetrahydroisoquinolines; Trabectedin

2005